Medicana Health Group, a cornerstone in global healthcare provision, is set to mark its presence in the UK, aiming to fulfill the heightened demand for distinguished healthcare services.
Medicana Health Group, renowned for its comprehensive and patient-first healthcare solutions, is announcing its strategic expansion into the UK, introducing its bespoke patient care and personalised treatment plans. This initiative is driven by the increasing trend towards private healthcare and insurance solutions, catalysed by the post-COVID landscape. At the core of Medicana’s approach is a deep-seated commitment to “active listening and personalised attention,” ensuring a nuanced understanding and fulfillment of each patient’s individual needs, thereby guaranteeing a healthcare experience that is tailored from the first consultation to aftercare, with the ambition of setting new benchmarks in the UK’s private healthcare industry.
Emphasising “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group is determined to provide a patient experience that is both deeply personalised and impeccably orchestrated, drawing from their proven track record in Türkiye to initiate a transformative wave in private healthcare across the UK.
Diving into the £282 Billion UK Healthcare Market
The UK’s private healthcare sector has seen a resurgence in the wake of the pandemic, primarily driven by the swell in self-pay patients. An ever-increasing number of individuals are choosing private healthcare as a means to bypass the NHS’s extensive wait times and to leverage the superior services and expertise of the independent sector. According to the Akeso report, the total healthcare expenditure in the UK for 2022 stood at an estimated £282 billion, with public spending contributing around 80% and private spending accounting for the remaining 20%.
With this burgeoning market in sight, Medicana is poised to apply its extensive expertise and a wide range of care services to make significant strides into the UK’s private healthcare market. By introducing its validated model of comprehensive care, from advanced diagnostics to specialised treatments, Medicana is equipped to meet the growing demand for exemplary private healthcare. The group’s dedication to excellence, coupled with its innovative patient care strategies, positions Medicana as a key player in addressing the UK’s healthcare demands.
Providing Care to 5.5 Million Patients Annually
Annually, Medicana Health Group delivers exemplary healthcare to over 5.5 million patients worldwide, supported by its 16 hospitals equipped with a substantial bed capacity. This not only illustrates their extensive experience in premium healthcare provision but also their capability to cater to the diverse healthcare needs of an international patient base. The expansion of Medicana Health Group into the UK market is expected to mark a significant move towards more compassionate, efficient, and personalised healthcare, starting a new chapter in their commitment to advancing patient well-being and healthcare standards internationally.
With an extensive history of more than 30 years, Medicana’s medical proficiency spans a wide range of specialties, providing advanced services in fields such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Since 2016, Medicana Health Group has also ventured into the educational realm, offering a comprehensive array of educational programmes from early childhood education to university level, both within Türkiye and on a global scale.
